new oral cancer drugs, Nexavar and Sutent
March 2006
You'll see two new oral cancer drugs, Nexavar and Sutent.
These drugs work similarly to Gleevec (imatinib). They block proteins involved in a tumor's growth and blood supply.
But Nexavar and Sutent target a wider range of proteins.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote